Company Filing History:
Years Active: 2020-2025
Title: Ariel Rothner: Innovator in Pharmaceutical Compositions
Introduction
Ariel Rothner is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in formulations for oral administration of active agents. With a total of 3 patents to his name, Rothner's work focuses on enhancing the efficacy of therapeutically active agents.
Latest Patents
Rothner's latest patents include innovative formulations designed for oral administration. One of his notable inventions involves pharmaceutical compositions that comprise a therapeutically active agent and an absorption enhancer, such as NAC, NAD, 5-CNAC, 4-MOAC, or 4-CNAB. These compositions are intended for the treatment of conditions that are responsive to the active agent. They allow for the concomitant oral administration of multiple unit dosage forms, which together provide a therapeutically effective amount of the active agent and an effective amount of the absorption enhancer. Another significant patent details a pharmaceutical composition that includes a therapeutically active agent, SNAC, and at least one antacid compound. This composition is designed to improve the oral administration of the active agent, ensuring better absorption and efficacy.
Career Highlights
Ariel Rothner is currently associated with Entera Bio Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new methods and compositions that enhance the delivery and effectiveness of therapeutic agents.
Collaborations
Rothner collaborates with esteemed colleagues such as Gregory Burshtein and Phillip M Schwartz, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Ariel Rothner's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical treatments through innovative formulations. His work not only enhances the effectiveness of therapeutic agents but also paves the way for future advancements in the field.